Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
The American Journal of Gastroenterology
|
June 6, 2018
Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry
Geert DʼHaens, Walter Reinisch, Remo Panaccione, et al.
Journal of Crohn'S & Colitis
|
November 6, 2016
Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial
Walter Reinisch, Jean-Frédéric Colombel, Geert D'Haens, et al.
Inflammatory Intestinal Diseases
|
September 18, 2018
Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance Therapy
Satoshi Motoya, Mamoru Watanabe, Kori Wallace, et al.
Gut
|
January 7, 2011
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
Walter Reinisch, William J Sandborn, Daniel W Hommes, et al.
JACC. Heart Failure
|
March 14, 2014
Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure
Milton Packer, Wilson Colucci, Lloyd Fisher, et al.
Nature Reviews. Drug Discovery
|
June 5, 2020
Cloud-based data systems in drug regulation: an industry perspective
Andrew S Robertson, Hilary Malone, Fabio Bisordi, et al.
Clinical and Translational Science
|
April 9, 2022
A vision for integrated publicly available information on regulated medical products
Khyati Roberts, Roopal Thakkar, Lina Aljuburi, et al.
Clinical Pharmacology and Therapeutics
|
April 28, 2020
Creating E-Labeling Platforms: An Industry Vision
Khyati Roberts, Roopal Thakkar, Deborah Autor, et al.
Clinical Pharmacology and Therapeutics
|
September 29, 2020
COVID-19: A Catalyst to Accelerate Global Regulatory Transformation
Jerry Stewart, Peter Honig, Lina AlJuburi, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
The American Journal of Gastroenterology
|
June 6, 2018
Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry
Geert DʼHaens, Walter Reinisch, Remo Panaccione, et al.
Journal of Crohn'S & Colitis
|
November 6, 2016
Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial
Walter Reinisch, Jean-Frédéric Colombel, Geert D'Haens, et al.
Inflammatory Intestinal Diseases
|
September 18, 2018
Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance Therapy
Satoshi Motoya, Mamoru Watanabe, Kori Wallace, et al.
Gut
|
January 7, 2011
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
Walter Reinisch, William J Sandborn, Daniel W Hommes, et al.
JACC. Heart Failure
|
March 14, 2014
Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure
Milton Packer, Wilson Colucci, Lloyd Fisher, et al.
Nature Reviews. Drug Discovery
|
June 5, 2020
Cloud-based data systems in drug regulation: an industry perspective
Andrew S Robertson, Hilary Malone, Fabio Bisordi, et al.
Clinical and Translational Science
|
April 9, 2022
A vision for integrated publicly available information on regulated medical products
Khyati Roberts, Roopal Thakkar, Lina Aljuburi, et al.
Clinical Pharmacology and Therapeutics
|
April 28, 2020
Creating E-Labeling Platforms: An Industry Vision
Khyati Roberts, Roopal Thakkar, Deborah Autor, et al.
Clinical Pharmacology and Therapeutics
|
September 29, 2020
COVID-19: A Catalyst to Accelerate Global Regulatory Transformation
Jerry Stewart, Peter Honig, Lina AlJuburi, et al.
Page
of 2